Spyre Therapeutics, Inc. (SYRE) has 4 open-market insider trades by 2 insiders since 2024. Over the last six months insiders net sold $401.0M. The most active filer is Scott L. Burrows, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Dir | — | 1 | $399.7M | 2026-06-23 |
| Scott L. Burrows | CFO | — | 3 | $3.0M | 2026-10-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Heidy King-Jones | — | Sell | $2.6M | 2026-10-01 |
| Cameron Turtle | CEO | Sell | $1.4M | 2026-10-01 |
| Scott L. Burrows | CFO | Sell | $2.3M | 2026-09-30 |
| Scott L. Burrows | CFO | Sell | $2.3M | 2026-09-01 |
| Cameron Turtle | CEO | Sell | $1.3M | 2026-09-01 |
| Heidy King-Jones | — | Sell | $2.5M | 2026-09-01 |
Companies that share insiders with SYRE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jeffrey W. Albers | Director | Sell | $2.4M | 2026-08-07 |
| Cameron Turtle | CEO | Sell | $1.4M | 2026-08-03 |
| Scott L. Burrows | CFO | Sell | $717K | 2026-08-03 |
| Cameron Turtle | CEO | Sell | $1.3M | 2026-07-01 |
| Sheldon Sloan | — | Sell | $731K | 2026-07-01 |
| Scott L. Burrows | CFO | Sell | $658K | 2026-07-01 |
| Scott L. Burrows | CFO | Sell | $1.3M | 2026-06-25 |
| Fairmount Funds Management LLC | Director | Sell | $399.7M | 2026-06-23 |
| Michael Thomas Henderson | Director | Sell | $2.0M | 2026-06-22 |